Read More Pharma Industry News Pfizer beats Q2 2025 earnings expectations and raises profit forecast, but long-term growth questions persist Pfizer beats Q2 2025 estimates and raises profit guidance, but patent expirations and pricing pressures keep long-term growth questions on the table. byPallavi MadhirajuAugust 11, 2025